BARFRESH FOOD GROUP INC. 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2026 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________________ to ___________________ Commission File Number: 001-41228 BARFRESH FOOD GROUP INC. (Exact name of registrant as specified in its charter) Delaware 27-1994406 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 12100 Wilshire Blvd. , 8 th Floor , Los Angeles , California 90025 (Address of principal executive offices) (Zip Code) 310 - 598-7113 (Registrant’s telephone number, including area code) Not Applicable (Former name, former address and former fiscal year, if changed since last report) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common stock, $0.000001 par value BRFH The Nasdaq Capital Market Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☐ Smaller reporting company ☒ Emerging growth company ☐ If an emerging growth company, indicate by the check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒ Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 16,143,501 shares as of May11, 2026. TABLE OF CONTENTS Page Number PART I – FINANCIAL INFORMATION Item 1. Financial Statements. 3 Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations. 15 Item 3. Quantitative and Qualitative Disclosures About Market Risk. 18 Item 4. Controls and Procedures. 18 PART II – OTHER INFORMATION 19 Item 1. Legal Proceedings. 19 Item 1A. Risk Factors. 19 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds. 19 Item 3. Defaults Upon Senior Securities. 19 Item 4. Mine Safety Disclosures. 19 Item 5. Other Information. 19 Item 6. Exhibits . 20 SIGNATURES 20 2 Item 1. Financial Statements. Barfresh Food Group Inc. Condensed Consolidated Balance Sheets March 31, December 31, 2026 2025 (unaudited) (audited) Assets Current assets: Cash $ 1,824,000 $ 325,000 Trade accounts receivable, net 2,280,000 1,957,000 Other receivables 22,000 99,000 Inventory, net 1,805,000 1,665,000 Prepaid expenses and other current assets 237,000 182,000 Total current assets 6,168,000 4,228,000 Property, plant and equipment, net of depreciation 8,361,000 8,297,000 Intangible assets, net of amortization 125,000 125,000 Other non-current assets 180,000 180,000 Total assets $ 14,834,000 $ 12,830,000 Liabilities and Stockholders’ Equity Current liabilities: Line of credit $ 527,000 $ 1,124,000 Accounts payable - trade 1,703,000 3,086,000 Accounts payable - construction in progress 1,861,000 2,433,000 Disputed co-manufacturer accounts payable (Note 5) 499,000 499,000 Accrued expenses 286,000 388,000 Accrued payroll and employee related expenses 139,000 173,000 Financing agreements - current 308,000 296,000 Notes payable 441,000 3,031,000 Total current liabilities 5,764,000 11,030,000 Financing agreements 483,000 470,000 Convertible notes, net of $ 619,000 discount at March 31, 2026 6,909,000 - Total liabilities 13,156,000 11,500,000 Commitments and contingencies - - Stockholders’ equity: Preferred stock, $ 0.000001 par value, 400,000 shares authorized, none issued or outstanding - - Common stock, $ 0.000001 par value; 23,000,000 shares authorized; and 16,104,853 and 15,969,281 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively - - Additional paid in capital 68,654,000 67,645,000 Accumulated deficit ( 66,976,000 ) ( 66,315,000 ) Total stockholders’ equity 1,678,000 1,330,000 Total liabilities and stockholders’ equity $ 14,834,000 $ 12,830,000 See the accompanying notes to the condensed consolidated financial statements 3 Barfresh Food Group Inc. Condensed Consolidated Statements of Operations For the three months ended March 31, 2026 and 2025 (Unaudited) 2026 2025 For the three months ended March 31, 2026 2025 Revenue $ 5,632,000 $ 2,930,000 Cost of revenue 4,599,000 2,030,000 Gross profit 1,033,000 900,000 Operating expenses: Selling, marketing and distribution 697,000 824,000 General and administrative 755,000 747,000 Depreciation and amortization 17,000 67,000 Total operating expenses 1,469,000 1,638,000 Loss from operations ( 436,000 ) ( 738,000 ) Interest expense 225,000 23,000 Net loss $ ( 661,000 ) $ ( 761,000 ) Per share information - basic and fully diluted: Weighted average shares outstanding 16,044,596 15,387,665 Net loss per share $ ( 0.04 ) $ ( 0.05 ) See the accompanying notes to the condensed consolidated financial statements 4 Barfresh Food Group Inc. Consolidated Statements of Cash Flows For the three months ended March 31, 2026 and 2025 (Unaudited) 2026 2025 For the three months ended March 31, 2026 2025 Net loss $ ( 661,000 ) $ ( 761,000 ) Adjustments to reconcile net loss to net cash used in operating activities Stock-based compensation 101,000 158,000 Depreciation and amortization 72,000 74,000 Amortization of financing discounts 33,000 4,000 Changes in assets and liabilities Accounts receivable ( 323,000 ) ( 670,000 ) Other receivables 77,000 ( 57,000 ) Inventories ( 140,000 ) 372,000 Prepaid expenses and other assets ( 55,000 ) ( 66,000 ) Accounts payable - trade ( 1,383,000 ) 222,000 Accrued expenses ( 103,000 ) 218,000 Net cash used in operating activities ( 2,382,000 ) ( 506,000 ) Investing activities Purchase of property and equipment ( 646,000 ) ( 28,000 ) Net cash used in investing activities ( 646,000 ) ( 28,000 ) Financing activities Borrowings under line of credit 3,791,000 782,000 Repayment of line of credit ( 4,398,000 ) ( 1,402,000 ) Issuance of convertible debt and warrants, net of $ 154,000 issuance cost 7,374,000 - Repayment of mortgage note ( 2,170,000 ) - Financing agreement payments ( 70,000 ) ( 23,000 ) Issuance of common stock, net of $ 26,000 issuance cost - 2,974,000 Shares repurchased for income tax withholding under stock compensation program - ( 160,000 ) Net cash provided by financing activities 4,527,000 2,171,000 Net increase in cash 1,499,000 1,637,000 Cash, beginning of period 325,000 235,000 Cash, end of period $ 1,824,000 $ 1,872,000 Cash paid for interest $ 185,000 $ 19,000 Non-cash financing and investing activities: Conversion of notes payable to equity $ 420,000 $ - Financed acquisition of long-term assets $ 95,000 $ - Accounts payable arising from acquisition of long-term assets $ 15,000 $ - Issuance of warrants to brokers in convertible debt and warrant offering $ 4,000 $ - See the accompanying notes to the condensed consolidated financial statements 5 Barfresh Food Group Inc. Notes to Condensed Consolidated Financial Statements March 31, 2026 (Unaudited) Note 1. Description of the Business, Basis of Presentation, and Summary of Significant Accounting Policies Barfresh Food Group Inc., (“we,” “us,” “our,” and the “Company”) was incorporated on February 25, 2010 in the State of Delaware. The Company is engaged in the manufacturing and distribution of frozen beverages and food, including ready-to-drink and ready-to-blend smoothies, shakes, frappes and ice cream mix, and raw and processed milk. Basis of Presentation The accompanying condensed consolidated financial statements are unaudited, except for the condensed balance sheet as of December 31, 2025. These unaudited interim condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and applicable rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and footnote disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Accordingly, these interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements for the fiscal year ended December 31, 2025 included in the Company’s Annual Report on Form 10-K, as filed with the SEC on April 15, 2026. In management’s opinion, the unaudited interim condensed consolidated financial statements reflect all adjustments, which are of a normal and recurring nature, that are necessary for a fair presentation of financial results for the interim periods presented. Operating results for any quarter are not necessarily indicative of the results for the full fiscal year. Principles of Consolidation The consolidated financial statements include the financial statements of the Company and our wholly-owned subsidiaries, Barfresh Inc. and Barfresh Corporation Inc. (formerly known as Smoothie, Inc.), and Arps Dairy, Inc. All inter-company balances and transactions among the companies have been eliminated upon consolidation. Use of Estimates The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets and revenues and expenses during the years reported. Actual results may differ from these estimates. Vendor Concentrations Since the Acquisition, Arps Dairy has commenced production of virtually all of the Company’s legacy product lines. Historically, the Company was exposed to supply risk as a result of concentration in its vendor base resulting from the use of a limited number of contract manufacturers. A comparison of production by source is summarized in the table below: Schedule of Contract Manufacturers Percentage of Finished Goods 2026 2025 Three months ended March 31, 2026 2025 Owned production facility 53 % - % Co-manufactured: Manufacturer A 18 % 52 % Manufacturer B - % 38 % Manufacturer C 26 % 10 % Manufacturer D 3 % - % Concentration risk, percentage 3 % - % 6 Manufacturer A gave notice that it would not renew our contract when it concluded in February 2026. Additionally, in December 2025, Manufacturer B discontinued manufacturing our products. Approximately 30% of our revenue in the quarter ended March 31, 2026 was produced in 2025, prior to the discontinuance. The commencement of production at Arps Dairy is a significant step towards mitigating the impact of these losses, and the potential adverse effect on our business, financial condition and results of operations. Summary of Significant Accounting Policies There have been no changes to our significant accounting policies described in our Annual Report on Form 10-K for the year ended December 31, 2025, as filed with the SEC on April 15, 2026 that have had a material impact on our condensed consolidated financial statements and related notes. Financial Instruments The Company’s financial instruments consist of cash, accounts receivable, accounts payable, the line of credit, financing agreements, notes payable and convertible notes. The carrying value of the Company’s financial instruments approximates their fair value. Accounts Receivable and Allowances Accounts receivable are recorded and carried at the original invoiced amount less allowances for credits and for any potential uncollectible amounts due to credit losses. We make estimates of the expected credit and collectability trends for the allowance for credit losses based on our assessment of various factors, including historical experience, the age of the accounts receivable balances, credit quality of our customers, current economic conditions, and other factors that may affect our ability to collect from our customers. Expected credit losses are recorded as general and administrative expenses on our condensed consolidated statements of operations. As of March 31, 2026 and December 31, 2025, there was no allowance for credit losses. There was no credit loss expense for the three months ended March 31, 2026 and 2025. Government Grant The Company has been awarded a $ 2,400,000 government grant to fund 50% of equipment purchases for the New Facility. As of March 31, 2026, there have been no assets acquired that are eligible for reimbursement under the grant. The Company expects to early adopt the Financial Accounting Standards Board’s Accounting Standards Update 2025-10, Government Grants. Grant proceeds will reduce the value of the assets acquired and the resulting depreciation expense over the estimated useful lives of the assets acquired. Derivative Liability The Company evaluates its convertible instruments, options, warrants or other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for under ASC 815, Derivatives and Hedging. The Company determined that its convertible instruments issued in 2026 did not include embedded derivatives that required bifurcation due to the scope exception in ASC 815. Revenue Recognition In accordance with ASC 606, Revenue from Contracts with Customers, revenue is recognized when a customer obtains ownership of promised goods. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for these goods. The Company applies the following five steps: 1) Identify the contract with a customer A contract with a customer exists when (i) the Company enters into an enforceable contract with a customer that defines each party’s rights, (ii) the contract has commercial substance and, (iii) the Company determines that collection of substantially all consideration for goods or services that are transferred is probable. For the Company, the contract is the approved sales order, which may also be supplemented by other agreements that formalize various terms and conditions with customers. 2) Identify the performance obligation in the contract Performance obligations promised in a contract are identified based on the goods or services that will be transferred to the customer. For the Company, this consists of the delivery of frozen beverages, which provide immediate benefit to the customer. 7 3) Determine the transaction price The transaction price is determined based on the consideration to which the Company will be entitled in exchange for transferring goods and is generally stated on the approved sales order. Variable consideration, which typically includes rebates or discounts, are estimated utilizing the most likely amount method. Provisions for refunds are generally provided for in the period the related sales are recorded, based on management’s assessment of historical and projected trends. 4) Allocate the transaction price to performance obligations in the contract Since the Company’s contracts contain a single performance obligation, delivery of frozen beverages, the transaction price is allocated to that single performance obligation. 5) Recognize revenue when or as the Company satisfies a performance obligation The Company recognizes revenue from the sale of frozen beverages when title and risk of loss passes and the customer accepts the goods, which generally occurs at the time of delivery to a customer warehouse. Customer sales incentives such as volume-based rebates or discounts are treated as a reduction of sales at the time the sale is recognized. Shipping and handling costs are treated as fulfilment costs and presented in distribution, selling and administrative costs. Storage and Shipping Costs Storage and outbound freight costs are included in selling, marketing and distribution expense. For the three months ending March 31, 2026 and 2025, storage and outbound freight totaled approximately $ 443,000 and $ 391,000 , respectively. Research and Development Expenditures for research activities relating to product development and improvement are charged to expense as incurred. The Company incurred approximately $ 24,000 and $ 19,000 in research and development expense for the three months ended March 31, 2026 and 2025, respectively. Loss Per Share For the three months ended March 31, 2026 and 2025, common stock equivalents have not been included in the calculation of net loss per share as their effect is anti-dilutive as a result of losses incurred. Recent Pronouncements From time to time, new accounting pronouncements are issued that we adopt as of the specified effective date. We have not determined if the impact of recently issued standards that are not yet effective will have an impact on our results of operations and financial position. Note 2. Inventory Inventory consists of the following: Schedule of Inventory March 31, December 31, 2026 2025 Raw materials and packaging $ 957,000 $ 684,000 Finished goods 848,000 981,000 Inventory, net $ 1,805,000 $ 1,665,000 8 Note 3. Property Plant and Equipment Property and equipment, net consist of the following: Schedule of Property and Equipment March 31, December, 31 2026 2025 Land $ 357,000 $ 357,000 Building 1,834,000 1,834,000 Manufacturing equipment 2,559,000 2,335,000 Customer equipment 1,426,000 1,426,000 Construction in progress 5,051,000 5,139,000 Property and equipment, gross 11,227,000 11,091,000 Less: accumulated depreciation ( 2,866,000 ) ( 2,794,000 ) Property and equipment, net of depreciation $ 8,361,000 $ 8,297,000 Depreciation expense related to these assets was approximately $ 72,000 and $ 53,000 for the three-months periods ending March 31, 2026 and 2025, respectively. Depreciation expense in cost of revenue was $ 55,000 and $ 7,000 for the three-month periods ending March 31, 2026 and 2025, respectively. Assets subject to financing leases consist of the following: Schedule of Assets Subject to Finance Leases March 31, December, 31 2026 2025 Manufacturing equipment $ 118,000 $ 106,000 Customer equipment 33,000 33,000 Construction in progress 921,000 866,000 Property and equipment, gross 1,072,000 1,005,000 Less: accumulated depreciation ( 20,000 ) ( 15,000 ) Property and equipment, net of depreciation $ 1,052,000 $ 990,000 Depreciation expense related to leased assets amounted to $ 5,000 and $ 2,000 for the three-month periods ending March 31, 2026 and 2025, respectively. Note 4. Debt Line of Credit In August 2024, the Company secured receivables financing of $ 1,500,000 (the “Barfresh Facility”), and amended the facility in September 2025 to increase the available financing to $ 2,500,000 . In October 2025, the Company secured receivables financing of $ 1,250,000 for Arps Dairy (together with the Barfresh Facility, the “Credit Facilities”). Under the Credit Facilities, the Company may borrow up to 90% of eligible customer account balances. Amounts outstanding bear interest at a rate based on the prime rate plus collateral fees, and are secured by accounts receivable and inventory. The weighted average rate was 8.2% and 8.7% March 31, 2026 and 2025, respectively. The Credit Facilities expire on their respective annual anniversaries, and renew automatically, unless notice is given or received . 9 As of March 31, 2026, there was $ 543,000 drawn under the Credit Facilities, and $ 3,207,000 was available to borrow, subject to available collateral. Unamortized deferred financing discount amounted to $ 16,000 as of March 31, 2026. Financing Agreements The Company has entered into financing agreements to purchase equipment and software as a service, with a weighted average imputed or stated interest of 22 %. Amounts due under the agreements are due over a weighted average period of 31 months, with maturities as follows as of March 31, 2026: Schedule of Financing Agreements 2026 (9 months) $ 361,000 2027 411,000 2028 99,000 2029 149,000 2030 35,000 Total payments due 1,055,000 Less: interest ( 264,000 ) Financing agreements 791,000 Less: current portion ( 308,000 ) Financing agreements $ 483,000 Notes Payable Schedule Of Notes Payable March 31, December 31, 2026 2025 Manager note $ 41,000 $ 61,000 Advances from Arps Dairy former stockholders 400,000 800,000 Mortgage Note payable to bank in monthly installments of $ 22,000 including interest at 6.85 % with a balloon payment due January 1, 2026; secured by real property and personal guarantees of Arps’ former stockholders. - 2,170,000 Total payments due 441,000 3,031,000 Less: current portion ( 441,000 ) ( 3,031,000 ) Long-term portion $ - $ - On February 10, 2026, the Company elected to convert $ 400,000 of the Advances from Arps Dairy former stockholders and $ 20,000 of the manager note into 129,032 and 6,540 of the Company’s common stock, respectively. See Note 6. On March 5, 2026, the maturity date of the New Advances was extended to the earlier of October 1, 2026 or the receipt of financing secured by real estate owned by the Company. Additionally, the amendments provide that holder may elect to have interest paid in cash or shares valued at a 10 % discount to the volume-weighted average price of the common stock over the ten trading days immediately preceding the payment. The Mortgage Note was repaid in March 2026 with the proceeds of the convertible note and warrant issuance. Convertible Notes and Warrants Beginning on March 5, 2026 and through March 23, 2026, the Company obtained subscriptions for unsecured senior convertible promissory notes in the aggregate amount of $ 7,528,000 (the “Notes”) from accredited investors, including $ 230,000 ( 3.1 % ) sold to related parties. Net proceeds amounted to $ 7,374,000 , after cash issuance costs of $ 154,000 . The Notes bear interest at 10% per annum for the first 12 months of the 24-month term, regardless of earlier payment or conversion (the “Minimum Interest”), and are mandatorily convertible as to principal and interest into shares of the Company’s common stock at any time prior to maturity at the conversion price of $ 2.90 per share (the “Conversion Price”), if the common stock of the registrant trades at $ 4.35 per share (150% of the Conversion Price) for 20 out of the preceding 30 consecutive trading days. The holders of the Notes have the option on up to 10 occasions to convert all or any portion of the principal and interest into shares of the registrant’s common stock at the Conversion Price. The registrant may prepay the Notes at any time prior to maturity, subject to payment of the Minimum Interest, any other accrued but unpaid interest, and a prepayment penalty of 5% if the amount of the Note principal that is prepaid does not exceed 50% or a prepayment of 10% if the amount of the Note principal that is prepaid exceeds 50%. Interest is to be paid quarterly in arrears beginning April 1, 2026 and can be paid in either cash or shares of the registrant’s common stock at the election of the Company. If paid in stock, the shares must be registered and valued at a 10% discount to the 10-day volume-weighted average price. Purchasers of the Notes were issued 2,352,500 detachable warrants to purchase common stock (the “Warrants’) at a price of $ 3.20 per share (the “Exercise Price”) for a 4-year term from date of issuance in an amount equal to 100% of their investment amounts. The Company may call the Warrants (the “Call”) if the common stock of the registrant trades at or above $ 4.80 per share (150% of the Exercise Price) for 20 out of the preceding 30 consecutive trading days. Additionally, 22,655 broker warrants were issued at an exercise price of $ 3.48 per share for a 3-year term, expiring March 10, 2029. Should the Company sell any of its securities in a capital-raising transaction at a price lower than the Conversion Price while any Notes are outstanding, the Conversion Price will adjust to that lower price. The Warrant Exercise Price will adjust to a 10% premium to the new Note conversion price. 10 The warrants are legally detachable, separately exercisable and accounted for as equity. Additionally, the conversion feature meets the scope exception of ASC 815 and was not bifurcated from the debt host contract. At issuance, the Company allocated $ 484,000 of the net proceeds to the warrants using the relative fair value method. The warrants were valued using the Black-Scholes option pricing model, based on the difference between two options, representing the value of the warrant excluding the value derived from appreciation of the Company’s common stock in excess of the strike price of the Call, with the following Level 3 inputs: Schedule of Black-scholes Option Pricing Model Warrant Call Risk-free interest rate 3.5 % 3.5 % Expected volatility 90 % 90 % Expected term (years) 4 4 Expected dividends $ - $ - Stock price $ 2.76 $ 2.76 Exercise price $ 3.20 $ 4.80 The allocation resulted in a corresponding debt discount of $ 642,000 , inclusive of $ 148,000 in transaction costs, which is being amortized to interest expense over the term of the note using the effective interest method, resulting in $ 23,000 in interest expense for the three months ended March 31, 2026. Note 5. Commitments and Contingencies Lease Commitments, Construction and Demolition The Company leases headquarters office space under a non-cancelable operating lease which expired on March 31, 2023 and has been extended multiple times, most recently through March 31, 2026 . The Company’s periodic lease cost was approximately $ 20,000 for each of the three-month periods ending March 31, 2026 and 2025. The lease was not extended on March 31, 2026, and new commitments for headquarters facilities are leased on a month-to-month basis. During 2023, the Arps Dairy sold its manufacturing facility (the “Existing Facility”) and purchased a different facility, executing both transactions with the same counterparty. Following the exchange, Arps Dairy commenced to expand the acquired property to provide 44,000 square feet of production and office space (the “New Facility”). Arps Dairy continues to operate at the Existing Facility under a leasing arrangement. The initial lease term was 18 months, and the lease was classified as an operating lease. Additionally, the counterparty leases space at the New Facility. Neither party pays rent for the space that it occupies. In connection with the Acquisition, the lease on the Existing Facility was extended until September 30, 2026 to permit the completion of the New Facility. The Company is subject to penalties of $ 1,000 per day if it has not vacated and demolished the Existing Facility by September 30, 2026, subject to limitations if delays are caused by a force majeure event or construction-related delays that are beyond the Company’s reasonable control. As of March 31, 2026, the New Facility expansion is expected to cost $ 6,700,000 , including equipment to efficiently manufacture Barfresh legacy products (the “Construction Obligations”). The Company has incurred $ 4,840,000 , including $ 1,861,000 in Accounts Payable – Construction in Progress of which $ 1,782,000 is owed to the construction contractor. In conjunction with the Acquisition, the contractor agreed to forebear from filing a mechanics lien against the building through December 2, 2025. Additionally, the agreement with the contractor stipulates that if any portion of the balance remains outstanding after December 31, 2025, it will accrue interest at 8 % per annum from day sixty-one until repayment is received, subject to rate adjustment for scope modifications. The Company is liable for the demolition of the Existing Facility, once it has vacated the premises. The Company has been awarded a $ 100,000 grant to pay for the demolition, which expires on December 31, 2026 . No liability is currently recorded for the demolition as management believes the grant is sufficient to cover the liability. Legal Proceedings Schreiber Dispute The Company’s products are produced to its specifications through several contract manufacturers. One of the Company’s contract manufacturers (the “Manufacturer”) provided approximately 52 % and 42 % of the Company’s products in the years ended December 31, 2022 and 2021, respectively, under a Supply Agreement with an initial term through September 2025. Over the course of 2022, the Company experienced numerous quality issues with the case packaging utilized by the Manufacturer. In addition, in July of 2022, the Company began receiving customer complaints about the texture of the Company’s smoothie products produced by the Manufacturer. In response, the Company withdrew product from the market and destroyed on-hand inventory, withholding $ 499,000 in payments due to the Manufacturer. The Company attempted to resolve the issues based on the contractual procedures described in the Supply Agreement. However, on November 4, 2022, in response to a formal proposal of alternate resolutions, the Company received notification from the Manufacturer that it was denying any responsibility for the defective manufacture of the product. In response, on November 10, 2022, the Company filed a complaint in the United States District Court for the Central District of California, Western Division (the “Complaint”), claiming that the Manufacturer had not met its obligations under the Supply Agreement, and seeking economic damages. In response, the Manufacturer terminated the Supply Agreement. On January 20, 2023, the Company filed a voluntary dismissal of the Complaint which allowed the parties to reach a potential resolution outside of the court system. However, as the parties were once again unable to come to an agreement, the Company re-filed the Complaint in California State Court in August 2023 and continues to progress through the court system. 11 In May 2024, the Company entered into a non-recourse litigation financing arrangement which is expected to be adequate to pursue the Complaint to conclusion. In 2025, the California State Court heard on the merits of fraud claims included in the complaint and determined that there was sufficient evidence to allow the claims to be heard. A trial date has been set for April 2027. Due to the uncertainties surrounding the claim, the Company is not able to predict either the outcome or a range of reasonably possible recoveries that could result from its actions against the Manufacturer, and no gain contingencies have been recorded. The disruption in its supply resulting from the dispute has and will continue to adversely impact the Company’s results of operations and cash flow until a suitable resolution is reached or new sources of reliable supply at sufficient volume can be identified and developed, the timing of which is uncertain. The Company has mitigated the impact of the supply disruption with the introduction of its single-serve smoothie cartons; however, the product format has not been accepted by some customers or as a substitute for the bottle product in all use cases. Other legal matters From time to time, various lawsuits and legal proceedings may arise in the ordinary course of business. However, litigation is subject to inherent uncertainties and an adverse result in these or other matters may arise from time to time that may harm our business. We are currently the defendant in one legal proceeding for an amount less than $ 100,000 . Our legal counsel and management believe a material unfavorable outcome to be remote. Note 6. Stockholders’ Equity The following are changes in stockholders’ equity for the three months ended March 31, 2025 and 2026: Schedule of Changes in Stockholders’ Equity Additional Common Stock paid in Accumulated Shares Amount Capital (Deficit) Total Balance December 31, 2024 14,746,172 $ - $ 64,199,000 $ ( 63,621,000 ) $ 578,000 Issuance of common stock for equity compensation, net of shares repurchased for income tax withholding 121,082 - ( 160,000 ) - ( 160,000 ) Shares issued in settlement of former Arps shareholder and manager notes - - - - - Issuance of detachable warrants - - - - - Equity-based compensation expense - - 158,000 - 158,000 Registered issuance of common stock 1,052,793 - 2,974,000 - 2,974,000 Net loss - - - ( 761,000 ) ( 761,000 ) Balance March 31, 2025 15,920,047 $ - $ 67,171,000 $ ( 64,382,000 ) $ 2,789,000 Additional Common Stock paid in Accumulated Shares Amount Capital (Deficit) Total Balance December 31, 2025 15,969,281 $ - $ 67,645,000 $ ( 66,315,000 ) $ 1,330,000 Balance 15,969,281 $ - $ 67,645,000 $ ( 66,315,000 ) $ 1,330,000 Equity-based compensation expense - - 102,000 - 102,000 Shares issued in settlement of former Arps shareholder and manager notes 135,572 - 420,000 - 420,000 Issuance of detachable warrants - - 487,000 487,000 Net loss - - - ( 661,000 ) ( 661,000 ) Balance March 31, 2026 16,104,853 $ - $ 68,654,000 $ ( 66,976,000 ) $ 1,678,000 Balance 16,104,853 $ - $ 68,654,000 $ ( 66,976,000 ) $ 1,678,000 Warrants In association with the issuance of convertible notes (Note 4), 2,375,155 warrants were issued at a weighted average exercise price of $ 3.20 per share and remain outstanding as of March 31, 2026. The weighted average remaining term of the warrants is 3.9 years as of March 31, 2026. 12 Equity Incentive Plan As of March 31, 2026, the Company has $ 457,000 of total unrecognized share-based compensation expense relative to unvested options, stock awards and stock units, which is expected to be recognized over the remaining weighted average period of 2.2 years. Stock Options The following is a summary of stock option activity for the three months ended March 31, 2026: Schedule of Stock Options Activity Number of Options Weighted average exercise price per share Remaining term in years Outstanding on December 31, 2025 763,002 $ 4.60 5.3 Granted 1,923 $ 2.81 8.0 Forfeited ( 22,831 ) $ 2.53 Outstanding on March 31, 2026 742,094 $ 4.66 4.9 Exercisable, March 31, 2026 538,842 $ 5.39 3.6 The fair value of the options issued was calculated using the Black-Scholes option pricing model, based on the following: Summary of Fair Value of Options Using Black-Sholes Option Pricing Model 2026 Expected term (in years) 8.0 Expected volatility 98.3 % Risk-free interest rate 4.2 % Expected dividends $ - Weighted average grant date fair value per share $ 2.42 Restricted Stock and Performance Share Units There has been no change in restricted stock or performance share units since December 31, 2025. Note 7. Income Taxes ASC 740 requires a valuation allowance to reduce the deferred tax assets reported if, based on the weight of evidence, it is more than likely than not that some portion or all the deferred tax assets will not be recognized. Accordingly, at this time the Company has placed a valuation allowance on all tax assets. As of March 31, 2026, the estimated effective tax rate for 2026 was zero . There are open statutes of limitations for taxing authorities in federal and state jurisdictions to audit our tax returns from 2019 through the current period. Our policy is to account for income tax related interest and penalties in income tax expense in the statement of operations. For the three months ending March 31, 2026 and 2025, the Company did not incur any interest and penalties associated with tax positions. As of March 31, 2026, the Company did not have any significant unrecognized uncertain tax positions. Note 8. Business Combination On October 3, 2025, the Company acquired all of the outstanding stock of Arps Dairy, a dairy processing company, in a stock purchase accounted for as a business combination (the “Acquisition”). Arps results of operations have been included in the consolidated statement of operations since October 4, 2025. The following unaudited pro forma information presents the consolidated results of operations as if the acquisition had occurred on January 1, 2025: Schedule of Unaudited Pro Forma Information Presenting Consolidated Results of Operations 2026 2025 For the three months ended March 31, 2026 2025 Pro forma revenue $ 5,632,000 $ 7,585,000 Pro forma net loss $ ( 661,000 ) $ ( 1,223,000 ) Pro forma net loss per share, basic and fully diluted $ ( 0.04 ) $ ( 0.08 ) 13 This pro forma data is presented for informational purposes only and does not purport to be indicative of the results of future operations or of the results that would have occurred had the acquisition taken place in the periods noted above. Note 9. Business Segments As a result of the Acquisition, the Company operates in two business segments. The Chief Executive Officer is the chief operating decision maker (“CODM”) who assesses performance and allocates resources based on actual and projected operating results. The CODM reviews revenue and gross profit in evaluating the efficiency of strategies within each segment, ensuring that financial and operational resources are optimized and aligned with the Company’s overall strategic objectives. The tables below present selected segment data: Schedule of Business Combination Reportable Segment 2026 2025 Three months ended March 31, 2026 2025 Revenue Frozen beverages and food $ 3,066,000 $ 2,930,000 Raw and processed milk 2,566,000 - Revenue $ 5,632,000 $ 2,930,000 Gross profit Frozen beverages and food $ 905,000 $ 900,000 Raw and processed milk 128,000 - Gross profit 1,033,000 900,000 Unallocated: Total operating expenses ( 1,469,000 ) ( 1,638,000 ) Interest expense ( 225,000 ) ( 23,000 ) Net loss $ ( 661,000 ) $ ( 761,000 ) Note 10. Liquidity During the three months ended March 31, 2026, the Company used cash for operations of $ 2,382,000 . As of March 31, 2026, the Company had $ 1,824,000 cash and net current assets of $ 903,000 , exclusive of disputed co-manufacturer accounts payable (Note 5). The Company has a history of operating losses and negative cash flow, which are expected to improve with growth. As described more fully in Note 5, the dispute and subsequent contract termination with the Manufacturer has resulted in limitations in the Company’s ability to procure certain products necessary to achieve our growth projections and in elevated legal costs that were incurred before the Company obtained non-recourse litigation financing in 2025. The Acquisition is expected to alleviate the supply constraints. The Company increased its receivables-based line of credit in September 2025 to $ 2,500,000 . In October 2025, Arps Dairy secured a receivables-based line of credit of $ 1,250,000 . In February 2026, $ 420,000 of notes payable were converted to equity in accordance with the terms of the note agreements. In March 2026, the Company raised $ 7,528,000 through the sale of convertible promissory notes with a two year term. The proceeds were used to retire the Mortgage Note, and $ 646,000 in Construction Obligations incurred, as well fund working capital requirements. The Company plans to complete construction of the New Facility and pursue long-term real estate and equipment lease financing for the remaining Construction Obligations. Although alleviated, the Company’s financial position at March 31, 2026 and historical results raise substantial doubt about its ability to continue as a going concern. As described, the Company has completed steps to improve liquidity. The actions taken have resulted in the alleviation of the substantial doubt about the Company’s ability to continue as a going concern. 14 Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations. The following discussion should be read in conjunction with the financial information included elsewhere in this Quarterly Report on Form 10-Q (this “Report”), including our unaudited condensed consolidated financial statements and the related notes and with our audited consolidated financial statements and related notes included in our Annual Report on Form 10-K for the year ended December 31, 2025, as filed with the SEC on April 15, 2026, and other reports that we file with the SEC from time to time. References in this Quarterly Report on Form 10-Q to “us”, “we”, “our” and similar terms refer to Barfresh Food Group Inc. Cautionary Note Regarding Forward-Looking Statements This discussion includes forward-looking statements, as that term is defined in the federal securities laws, based upon current expectations that involve risks and uncertainties, such as plans, objectives, expectations, and intentions. Actual results and the timing of events could differ materially from those anticipated in these forward-looking statements as a result of a number of factors. Words such as “anticipate”, “estimate”, “plan”, “continuing”, “ongoing”, “expect”, “believe”, “intend”, “may”, “will”, “should”, “could” and similar expressions are used to identify forward-looking statements. We caution you that these statements are not guarantees of future performance or events and are subject to a number of uncertainties, risks and other influences, many of which are beyond our control, which may influence the accuracy of the statements and the projections upon which the statements are based. Any one or more of these uncertainties, risks and other influences could materially affect our results of operations and whether forward-looking statements made by us ultimately prove to be accurate. Our actual results, performance and achievements could differ materially from those expressed or implied in these forward-looking statements. We undertake no obligation to publicly update or revise any forward-looking statements, whether from new information, future events or otherwise. Critical Accounting Policies Our consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”). Results of Operations Results of Operation for the Three Months Ended March 31, 2026 as Compared to the Three Months Ended March 31, 2025 Revenue and cost of revenue Revenue increased $2,702,000, or 92%, to $5,632,000 in 2026 as compared to $2,930,000 in 2025. Arps Dairy contributed $2,837,000 to revenue, including $2,566,000 in raw and processed milk sales. The acquisition of Arps Dairy gives us the expanded capacity we have sought over the past three years, necessary to service our customer base and expand our sales reach. Cost of revenue increased $2,569,000, or 127%, to $4,599,000 in 2026 as compared to $2,030,000 in 2025. Cost of revenue increased at a higher rate compared to revenue due to the inclusion of the raw and processed milk operations after the Acquisition. Products in this segment are generally commodities with commensurate margins, but provide a strategic milk supply to the business and contribute to fixed overhead costs. Cost of revenue in the frozen beverages and food segment, which consisted primarily of Barfresh legacy products in 2026, increased at the same rate as revenue. 15 Our gross profit was $1,033,000 (18%) and $900,000 (31%) for 2026 and 2025, respectively. Gross profit from frozen beverages and food was $905,000 in 2026 (30%) compared to $900,000 in 2025 (31%). The slight decrease is due to product mix. Gross profit from raw and processed milk was $128,000 in 2026 (5%). Selling, marketing and distribution expense 2026 2025 Change Percent Sales and marketing $ 254,000 $ 433,000 $ (179,000 ) -41 % Storage and outbound freight 443,000 391,000 52,000 13 % $ 697,000 $ 824,000 $ (127,000 ) -15 % Selling, marketing and distribution expense decreased approximately $127,000 (15%) from approximately $824,000 in 2025 to $697,000 in 2026. Sales and marketing expense decreased approximately $179,000 (41%) from approximately $433,000 in 2025 to $254,000 in 2026. The decrease is a result of lower personnel costs as we rely more heavily on our broker network, as well as a decrease in sample expense, which was elevated in 2025 due to the introduction of our Pop & Go freeze pops. Additionally, equipment maintenance expense for machines provided to our customers for use with our bulk products decreased, as single serve products have become more prominent in the school setting. Storage and outbound freight expense increased approximately $52,000 (13%) from approximately $391,000 in 2025 to $443,000 in 2026, primarily due to costs associated with the delivery of processed milk at Arps Dairy. General and administrative expense 2026 2025 Change Percent Personnel costs $ 358,000 $ 372,000 $ (14,000 ) -4 % Stock based compensation 102,000 158,000 (56,000 ) -35 % Legal, professional and consulting fees 107,000 81,000 26,000 32 % Research and development 24,000 19,000 5,000 26 % Other general and administrative expenses 142,000 117,000 25,000 21 % Business acquisition expense 22,000 - 22,000 nm $ 755,000 $ 747,000 $ 8,000 1 % General and administrative expenses increased approximately $8,000 (1%) from approximately $747,000 in 2025 to $755,000 in 2026. Personnel cost represents the cost of employees including salaries, bonuses, employee benefits and employment taxes. Personnel cost decreased by approximately $14,000 (4%) from approximately $372,000 in 2025 to $358,000 in 2026. The decrease in personnel cost resulted from decreased head count, and lower employer payroll taxes due to timing of vesting of stock-based compensation. Stock-based compensation decreased by approximately $56,000 (35%) from $158,000 in 2025 to $102,000 in 2026 as a result of lower expected attainment under our performance stock unit program. Legal, professional and consulting fees increased by approximately $26,000 (32%) from $81,000 in 2025 to $107,000 in 2026 due to costs of temporary personnel associated with integration of Arps Dairy. Other general and administrative expenses increased by approximately $25,000 (21%) due to travel costs associated with the integration of Arps Dairy. 16 Interest Expense Interest expense was $225,000 in 2026 compared to $23,000 in 2025. The increase of $202,000 is a result of mortgage debt, notes and lease financing related to the Acquisition and the purchase of equipment required for the New Facility, as well as the issuance of $7,528,000 of convertible notes in March 2026. Net loss We had net losses of approximately $661,000 and $761,000 for the three-month periods ending March 31, 2026 and 2025, respectively. The decrease in net loss of approximately $100,000 was primarily due to a decrease in the loss from operations of $302,000, offset by an increase of $202,000 in interest expense incurred related to the acquisition of Arps Dairy and the build out of the New Facility. Liquidity and Capital Resources On February 5, 2025, we entered into securities purchase agreements with several investors, pursuant to which the Company sold an aggregate of 1,052,793 shares of common stock at a price of $2.85 per share in a registered direct offering, raising $2,974,000. Our continuing dispute with the Manufacturer and the resulting loss of product supply in 2022 negatively impacted our financial position, results of operations and cash flow. Subsequently, we contracted with a co-manufacturer for additional smoothie bottle manufacturing capacity. While expanded capacity became available from manufacturer C in the fourth quarter of 2024, we were notified in 2025 that manufacturers A and B elected to discontinue production of smoothie bottles and smoothie cartons in January 2026 and December 2025, respectively. The Acquisition was undertaken to resolve constrained capacity experienced since 2022 under the co-manufacturing business model. In order to consummate the Acquisition, we paid $1,223,000, net of cash acquired, to purchase 100% of Arps Dairy stock. Additionally, we incurred $518,000 in acquisition costs in 2025. In order to finance the Acquisition, we increased our receivables-based line of credit in September 2025 to $2,500,000. As a result of the Acquisition, $5,251,000 of mortgage debt, construction related payables and advances from former shareholders payable by Arps Dairy became short-term financial commitments of the Company. The Acquisition was structured to allow us to take control of Arps Dairy manufacturing operations ahead of completing all necessary long-term financing activities. Following the Acquisition, Arps Dairy secured a receivables-based line of credit of $1,250,000. We acquired $823,000 of equipment through leasing transactions in 2025 and the first three months of 2026. In December 2025, we were granted $2,400,000 to fund up to 50% of the cost of new equipment purchases and installation for the New Facility. In February 2026, $400,000 of Arps selling shareholder advances were converted into shares of our common stock. In March 2026, we raised $7,528,000 through the sale of convertible promissory notes. The proceeds were used to retire $2,541,000 in mortgage debt and construction payables, and are expected to be used to repay remaining construction related payables as well as complete construction of the New Facility in 2026. During the quarter ended March 31, 2026, we used $2,382,000 in operations. Our net loss adjusted for non-cash operating expenses was a loss of $455,000, while changes in current assets and liabilities used $1,927,000 primarily because of settlements of amounts due to co-manufacturers who discontinued providing product in December 2025 and January 2026. 17 As of March 31, 2026, we had net current assets of $903,000, including $1,861,000 of construction payables, compared with net current liabilities of $6,303,000 on December 31, 2025. Disputed accounts payable due to the Manufacturer of $499,000 are excluded from both March 31, 2026 and December 31, 2025 amounts. Our operations to date have been financed by the sale of securities, the issuance of convertible and short-term debt and equipment leasing. Our liquidity needs will depend on careful management of the construction of the New Facility, as well as how quickly we are able to profitably ramp up sales, achieve manufacturing cost synergies anticipated as a result of the Acquisition, control and reduce variable operating expenses, and control fixed overhead expense. There are no assurances that the grant received in December 2025 and the proceeds from the sale of convertible promissory notes in March 2026 will be sufficient to carry out our current plan of operations. We anticipate that we will have additional sources of liquidity, if required, through mortgage financing supported by the guarantee of the United States Department of Agriculture, and equipment lease financing, among other options. However, there are no assurances that these funds will be available. If we are unable to generate sufficient cash flow from operations, control construction costs, or raise additional capital through debt issuances, we may be required to raise additional funds in the form of equity. Off-Balance Sheet Arrangements We have no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expense, results of operations, liquidity, capital expenditures or capital resources that are material to stockholders. Item 3. Quantitative and Qualitative Disclosures About Market Risk. Not required because we are a smaller reporting company. Item 4 . Controls and Procedures. Evaluation of Disclosure Controls and Procedures Under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer, we conducted an evaluation of our disclosure controls and procedures, as such term is defined under Securities and Exchange Act of 1934 Rule 13(a)-15(e). Disclosure controls and procedures are designed to provide reasonable assurance that the information required to be disclosed in the reports that we file or submit under the Exchange Act has been appropriately recorded, processed, summarized, and reported on a timely basis and are effective in ensuring that such information is accumulated and communicated to the Company’s management, as appropriate to allow timely decisions regarding required disclosure. Based on the evaluation of our disclosure controls and procedures as of March 31, 2026, our Chief Executive Officer and Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were not effective at the reasonable assurance level. Management has identified the following material weakness in our internal control over financial reporting: Management has concluded that there is a material weakness due to the control environment. The control environment is impacted due to the Company’s inadequate segregation of duties, primarily information technology control activities. Management recognizes that there are inherent limitations in the effectiveness of any system of internal control, and accordingly, even effective internal control can provide only reasonable assurance with respect to financial statement preparation and may not prevent or detect material misstatements. In addition, effective internal control at a point in time may become ineffective in future periods because of changes in conditions, such as those that occurred as a result of the business combination, or due to deterioration in the degree of compliance with our established policies and procedures. In an effort to remediate the identified material weakness and enhance our internal control over financial reporting, we will fully engage our information technology personnel to help ensure that we are able to properly implement internal control procedures. This report shall not be deemed to be filed for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, and is not incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing. Changes in Internal Control over Financial Reporting None. 18 PART II- OTHER INFORMATION Item 1. Legal Proceedings. As described in Note 5, the Company has an on-going dispute with the Manufacturer, the outcome of which cannot be predicted at this time. From time to time, various lawsuits and legal proceedings may arise in the ordinary course of business. However, litigation is subject to inherent uncertainties and an adverse result in these or other matters may arise from time to time that may harm our business. We are currently the defendant in one legal proceeding for an amount less than $100,000. Our legal counsel and management believe a material unfavorable outcome to be remote. Item 1A. Risk Factors. Not required because we are a smaller reporting company. Item 2. Unregistered Sales of Equity Securities and Use of Proceeds On February 10, 2026, the Company issued 135,572 restricted shares of its common stock, valued at $420,273, to the former shareholders of Arps Dairy, Inc. as payment of debt owed to these shareholders. From March 5, 2026 to March 23, 2026, the Company sold unsecured senior convertible promissory notes in the aggregate amount of $7,528,000 (the “Notes”) from accredited investors. The Notes bear interest at 10% per annum for the first 12 months of the 24-month term, regardless of earlier payment or conversion (the “Minimum Interest”), and is mandatorily convertible as to principal and interest into shares of the Company’s common stock at any time prior to maturity at the conversion price of $2.90 per share (the “Conversion Price”), if the common stock of the Company trades at $4.35 per share (150% of the Conversion Price) for 20 out of the preceding 30 consecutive trading days. The holders of the Notes have the option on up to 10 occasions to convert all or any portion of the principal and interest into shares of the Company’s common stock at the Conversion Price. The Company may prepay the Notes at any time prior to maturity, subject to payment of the Minimum Interest, any other accrued but unpaid interest, and a prepayment penalty of 5% if the amount of the Note principal that is prepaid does not exceed 50% or a prepayment of 10% if the amount of the Note principal that is prepaid exceeds 50%. Interest is to be paid quarterly in arrears beginning April 1, 2026 and can be paid in either cash or shares of the Company’s common stock at the election of the registrant. If paid in stock, the shares must be registered and valued at a 10% discount to the 10-day volume-weighted average price. Purchasers of the Notes were issued warrants to purchase common stock (the “Warrants’) at a price of $3.20 per share (the “Exercise Price”) for a 4-year term from date of issuance in an amount equal to 100% of their investment amounts. The Company may call the Warrants if the common stock of the registrant trades at $4.80 per share (150% of the Exercise Price) for 20 out of the preceding 30 consecutive trading days. Item 3. Defaults Upon Senior Securities. None. Item 4. Mine Safety Disclosures. Not applicable. Item 5. Other Information. None. 19 Item 6. Exhibits. Exhibit No. Description 4.1 Securities Purchase Agreement (incorporated by reference to Exhibit 4.1 to Current Report on Form 8-K as filed March 9, 2026) 10.1 Form of Amended and Restated Note to Arps Dairy Shareholders dated March 5, 2026 (incorporated by reference to Exhibit 10.7 to Annual Report on Form 10-K filed April 15, 2026) 31.1 Certification of Principal Executive Officer pursuant to Rule 13a-14(a) (filed herewith) 31.2 Certification of Principal Financial Officer pursuant to Rule 13a-14(a) (filed herewith) 32.1 Certification pursuant to 18 U.S.C. Section 1350 (furnished herewith) 101.INS Inline XBRL Instance Document* 101.SCH Inline XBRL Taxonomy Extension Schema Document* 101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document* 101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document* 101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document* 101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document* 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) *XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections. In accordance with SEC Release 33-8238, Exhibit 32.1 is furnished and not filed. 20 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. BARFRESH FOOD GROUP INC. Date: May 14, 2026 By: /s/ Riccardo Delle Coste Riccardo Delle Coste Chief Executive Officer (Principal Executive Officer) Date: May 14, 2026 By: /s/ Lisa Roger Chief Financial Officer (Principal Financial Officer) 21